Patients with moderate-to-severe atopic dermatitis may have a 20% increased risk of atrial fibrillation, finds a recent study.
Understanding the pattern of pruritus in various autoimmune connective tissue diseases may help physicians identify different etiologies that will inform different treatment targets to alleviate the symptom, according to researchers who examined pruritus relative to disease.
Psoriasis often has a greater impact on quality of life in patients with skin of color as the condition and its treatment can result in long-lasting pigmentary changes.
Drug development in acne is currently focused on targeting inflammation and reworking the vehicles of existing active drugs to increase their efficacy and tolerability, according to this expert.
An extract of Nigella seeds within a topical gel formulation has shown positive results as a potential treatment for acne vulgaris, according to a recent study.
Pain is a distinct and important symptom of atopic dermatitis experienced by almost two thirds of patients, reports a recent study.
Researchers recently analyzed insurance claims data to investigate the safety and efficacy of off-label immunomodulatory drugs for atopic dermatitis in real life practice. Read what they discovered here.
In this article, we highlight how sarecycline fits into the current treatment offerings for moderate-to-severe acne.
Acne patients are open to using effective antibiotic-free treatments if their prescriber offers them, says a recent study.
Atopic dermatitis presents differently depending on whether the patient is an adult or child. This means that different treatments may be more effective in an adult than children and vice versa.